NRX Pharmaceuticals (NRXP) Non Operating Investment Income (2017 - 2018)
NRX Pharmaceuticals' (NRXP) quarterly Non Operating Investment Income came in at -$74.0 in Q3 2018, down 104.42% on a QoQ basis from $1674.0 in Q2 2018.
NRX Pharmaceuticals (NRXP) Non Operating Investment Income (2017 - 2018) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 2 years of Non Operating Investment Income data on file, last reported at -$74.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn | - |
| 10 | NRX Pharmaceuticals | 117.83 Mn | 111.13 Mn | 437,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -74.00 |
| Sep 30, 2018 | -74.00 |
| Jun 30, 2018 | 1,674.00 |
| Jun 30, 2018 | 1,674.00 |
| Mar 31, 2018 | -1,599.00 |
| Mar 31, 2018 | -1,599.00 |
| Dec 31, 2017 | -4,740.00 |
| Dec 31, 2017 | -4,740.00 |